Xofluza Archives - PEPID Pulse

FDA Approves Xofluza, First New Treatment for Influenza in Nearly 20 Years.

by PEPID Newsroom | Oct 31, 2018 | Alerts

Yesterday the U.S. Food and Drug Administration approved Xofluza (balorxavir marhboxil), a new influenza treatment for acute uncomplicated influenza in people age 12 and older who have been symptomatic for no more than 2 days. This new drug, developed by Genentech,...

FDA Approves Xofluza, First New Treatment for Influenza in Nearly 20 Years.

Recent Posts

Categories